These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 35246952)

  • 1. Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer's disease with a comprehensive neuropsychological test.
    Yao L; Aoyama S; Ouchi A; Yamamoto Y; Sora I
    Neuropsychopharmacol Rep; 2022 Jun; 42(2):174-182. PubMed ID: 35246952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease.
    Ciafone J; Thomas A; Durcan R; Donaghy PC; Hamilton CA; Lawley S; Roberts G; Colloby S; Firbank MJ; Allan L; Petrides G; Taylor JP; O'Brien JT; Gallagher P
    J Int Neuropsychol Soc; 2022 Oct; 28(9):963-973. PubMed ID: 34666864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.
    Gu D; Lv X; Shi C; Zhang T; Liu S; Fan Z; Tu L; Zhang M; Zhang N; Chen L; Wang Z; Wang J; Zhang Y; Li H; Wang L; Zhu J; Zheng Y; Wang H; Yu X;
    J Med Internet Res; 2023 Dec; 25():e49147. PubMed ID: 38039074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    White JP; Schembri A; Prenn-Gologranc C; Ondrus M; Katina S; Novak P; Lim YY; Edgar C; Maruff P
    J Alzheimers Dis; 2023; 96(4):1781-1799. PubMed ID: 38007647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment profile in adolescent early-onset psychosis using the MATRICS Battery: Age and sex effects.
    Smelror RE; Johannessen C; Wedervang-Resell K; Jørgensen KN; Barth C; Andreou D; Ueland T; Andreassen OA; Myhre AM; Rund BR; Agartz I
    Neuropsychology; 2021 Mar; 35(3):300-309. PubMed ID: 33970663
    [No Abstract]   [Full Text] [Related]  

  • 12. Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients.
    Zhang B; Han M; Tan S; De Yang F; Tan Y; Jiang S; Zhang X; Huang XF
    Sci Rep; 2017 Sep; 7(1):11821. PubMed ID: 28928440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
    J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.